121 related articles for article (PubMed ID: 32761364)
1. Achilles tendon thickening is associated with higher incidence of adverse cardiovascular event in patients with coronary artery disease.
Hashimoto T; Minami Y; Asakura K; Katamine M; Kato A; Katsura A; Sato T; Muramatsu Y; Kakizaki R; Fujiyoshi K; Ishida K; Kameda R; Meguro K; Shimohama T; Ako J
Heart Vessels; 2021 Feb; 36(2):163-169. PubMed ID: 32761364
[TBL] [Abstract][Full Text] [Related]
2. Achilles Tendon Thickening as a Risk Factor of Cardiovascular Events after Percutaneous Coronary Intervention.
Matsumoto I; Kurozumi M; Namba T; Takagi Y
J Atheroscler Thromb; 2023 May; 30(5):491-501. PubMed ID: 35850983
[TBL] [Abstract][Full Text] [Related]
3. Achilles tendon thickening is associated with disease severity and plaque vulnerability in patients with coronary artery disease.
Hashimoto T; Minami Y; Kakizaki R; Nemoto T; Fujiyoshi K; Meguro K; Shimohama T; Tojo T; Ako J
J Clin Lipidol; 2019; 13(1):194-200. PubMed ID: 30472278
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of Achilles tendon thickness in elderly patients after percutaneous coronary intervention: A 5-year follow-up.
Isawa T; Horie K; Toyoda S; Taguri M
J Cardiol; 2023 Dec; 82(6):448-454. PubMed ID: 37506821
[TBL] [Abstract][Full Text] [Related]
5. Association between Achilles tendon xanthoma and severity of coronary artery disease in patients undergoing percutaneous coronary intervention.
Kitahara H; Nakayama T; Fujimoto Y; Kobayashi Y
J Cardiol; 2020 Jun; 75(6):654-658. PubMed ID: 31992496
[TBL] [Abstract][Full Text] [Related]
6. Achilles tendon thickness is associated with coronary lesion severity in acute coronary syndrome patients without familial hypercholesterolemia.
Fujiwara R; Yahiro R; Horio T; Miyauchi M; Yoshimura R; Matsuoka Y; Yokouchi G; Sakamoto Y; Matsumoto N; Fukuda K; Izumiya Y; Yoshiyama M; Fujimoto K; Kasayuki N
J Cardiol; 2022 Feb; 79(2):311-317. PubMed ID: 34657775
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Achilles tendon xanthoma and familial hypercholesterolemia in patients with coronary artery disease undergoing percutaneous coronary intervention.
Kitahara H; Mori N; Saito Y; Nakayama T; Fujimoto Y; Kobayashi Y
Heart Vessels; 2019 Oct; 34(10):1595-1599. PubMed ID: 30968218
[TBL] [Abstract][Full Text] [Related]
8. Genetic mutations, regression of Achilles tendon thickness, and cardiovascular events among patients with familial hypercholesterolemia.
Tada H; Okada H; Nohara A; Takamura M; Kawashiri MA
Atherosclerosis; 2022 Jan; 340():28-34. PubMed ID: 34871818
[TBL] [Abstract][Full Text] [Related]
9. Five-year outcomes of surgical or percutaneous myocardial revascularization in diabetic patients.
Contini GA; Nicolini F; Fortuna D; Pacini D; Gabbieri D; Vignali L; Valgimigli M; Manari A; Zussa C; Guastaroba P; De Palma R; Grilli R; Gherli T
Int J Cardiol; 2013 Sep; 168(2):1028-33. PubMed ID: 23164591
[TBL] [Abstract][Full Text] [Related]
10. Impact of changes in Achilles tendon thickening on cardiovascular events in patients with familial hypercholesterolemia.
Tada H; Kojima N; Takeji Y; Nohara A; Kawashiri MA; Takamura M
Am J Prev Cardiol; 2024 Jun; 18():100660. PubMed ID: 38590629
[TBL] [Abstract][Full Text] [Related]
11. Extent of lipid core plaque in patients with Achilles tendon xanthoma undergoing percutaneous coronary intervention for coronary artery disease.
Kitahara H; Yamazaki T; Hiraga T; Yamashita D; Matsumoto T; Kobayashi T; Sato T; Suzuki M; Saito K; Matsuoka T; Mori N; Tateishi K; Fujimoto Y; Kobayashi Y
J Cardiol; 2022 Apr; 79(4):559-563. PubMed ID: 34895790
[TBL] [Abstract][Full Text] [Related]
12. Association of Achilles tendon thickness and LDL-cholesterol levels in patients with hypercholesterolemia.
Wang B; Zhang Q; Lin L; Pan LL; He CY; Wan XX; Zheng ZA; Huang ZX; Zou CB; Fu MC; Kutryk MJ
Lipids Health Dis; 2018 Jun; 17(1):131. PubMed ID: 29859112
[TBL] [Abstract][Full Text] [Related]
13. Validation of the Coronary Artery Bypass Graft SYNTAX Score (Synergy Between Percutaneous Coronary Intervention With Taxus) as a Prognostic Marker for Patients With Previous Coronary Artery Bypass Graft Surgery After Percutaneous Coronary Intervention.
Miyagi T; Asaumi Y; Nishimura K; Nakashima T; Sakamoto H; Nakao K; Kanaya T; Nagai T; Shimabukuro Y; Miyamoto Y; Fujita T; Kusano K; Anzai T; Kobayashi J; Noguchi T; Ogawa H; Yasuda S
Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27578838
[TBL] [Abstract][Full Text] [Related]
14. Clinical impact of complete revascularization in elderly patients with multi-vessel coronary artery disease undergoing percutaneous coronary intervention: A sub-analysis of the SHINANO registry.
Harada M; Miura T; Kobayashi T; Kobayashi H; Kobayashi M; Nakajima H; Kimura H; Akanuma H; Mawatari E; Sato T; Hotta S; Kamiyoshi Y; Maruyama T; Watanabe N; Eisawa T; Hashizume N; Ebisawa S; Miyashita Y; Ikeda U;
Int J Cardiol; 2017 Mar; 230():413-419. PubMed ID: 28040276
[TBL] [Abstract][Full Text] [Related]
15. Impact of High-Density Lipoprotein Levels on Cardiovascular Outcomes of Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents.
Roumeliotis A; Claessen B; Dangas G; Torguson R; Sartori S; Reisman A; Cao D; Chandiramani R; Nicolas J; Goel R; Chiarito M; Sharma M; Bandyopadhyay D; Baber U; Sweeny J; Barman N; Sharma S; Kini A; Mehran R
Am J Cardiol; 2020 Dec; 137():1-6. PubMed ID: 33002465
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of nutritional status assessed by the Controlling Nutritional Status score in patients with stable coronary artery disease undergoing percutaneous coronary intervention.
Wada H; Dohi T; Miyauchi K; Doi S; Konishi H; Naito R; Tsuboi S; Ogita M; Kasai T; Okazaki S; Isoda K; Suwa S; Daida H
Clin Res Cardiol; 2017 Nov; 106(11):875-883. PubMed ID: 28634674
[TBL] [Abstract][Full Text] [Related]
17. Impact of polyvascular disease on clinical outcomes in patients undergoing coronary revascularization: an observation from the CREDO-Kyoto Registry Cohort-2.
Morikami Y; Natsuaki M; Morimoto T; Ono K; Nakagawa Y; Furukawa Y; Sakata R; Aota M; Okada Y; Onoe M; Kawasuji M; Koshiji T; Nakajima H; Nishizawa J; Yamanaka K; Yamamoto H; Kimura T;
Atherosclerosis; 2013 Jun; 228(2):426-31. PubMed ID: 23623262
[TBL] [Abstract][Full Text] [Related]
18. Impact of serum albumin levels on long-term outcomes in patients undergoing percutaneous coronary intervention.
Wada H; Dohi T; Miyauchi K; Shitara J; Endo H; Doi S; Naito R; Konishi H; Tsuboi S; Ogita M; Kasai T; Okazaki S; Isoda K; Suwa S; Daida H
Heart Vessels; 2017 Sep; 32(9):1085-1092. PubMed ID: 28429111
[TBL] [Abstract][Full Text] [Related]
19. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
[TBL] [Abstract][Full Text] [Related]
20. Routine angiographic follow-up versus clinical follow-up in patients with multivessel coronary artery diseases following percutaneous coronary intervention with drug-eluting stents: a nested case-control study within a Korean population.
Kim YH; Her AY; Rha SW; Choi BG; Shim M; Choi SY; Byun JK; Li H; Kim W; Kang JH; Choi JY; Park EJ; Park SH; Lee S; Na JO; Choi CU; Lim HE; Kim EJ; Park CG; Seo HS; Oh DJ
Coron Artery Dis; 2017 Jun; 28(4):307-314. PubMed ID: 28272162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
